Acambis Wins IR Magazine's Grand Prix for Best Smaller Company Investor Relations.CAMBRIDGE, England & CAMBRIDGE, Mass. -- At IR Magazine's UK annual awards held on Tuesday, 14 June, Acambis (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ACAM ACAM American College for Advancement in Medicine ACAM Autorité de Contrôle des Assurances et des Mutuelles (French organization regulating insurance companies and mutual funds) ACAM Annonces Classees A Montreal ) (LSE LSE - Language Sensitive Editor :ACM) triumphed to win the Grand Prix for Best Smaller Company Investor Relations award. It was one of four companies short-listed for the award. The award was received by Lyndsay Wright, Acambis' Vice President, Communications and Investor Relations at a glittering ceremony held at London's Old Billingsgate Billingsgate (bĭl`ĭngzgĭt, –gāt), wharf and fish market, London, England, on the north bank of the Thames River. The market was named after a river gate in the old city wall. and attended by more than 800 IR-related professionals. TV personality Jimmy Carr presented the winners with their awards. The competition was judged by analysts and fund managers who were tasked with selecting the company that, in their opinion, has the 'best overall IR' in the category. The Best Smaller Company IR award is one of three "Grand Prix" awards, the other two being "Best overall IR" and "Best FTSE FTSE A company that specializes in index calculation. Although not part of a stock exchange, co-owners include the London Stock Exchange and the Financial Times. Notes: The FTSE is similar to Standard & Poor's in the United States. 250 IR". The IR Magazine awards are renowned worldwide for showcasing the industry's best in shareholder communications. Over 600 sell-side analysts, buy-side analysts, portfolio managers and retail investors participate in the awards and compile a short-list before deciding on the overall winner. Lyndsay Wright, VP, Communications and Investor Relations collected the award on behalf of Acambis and commented: "We are honoured to be awarded IR Magazine's Grand Prix for Best Smaller Company Investor Relations, and delighted to have our IR activities recognised by our stakeholders and our peer group. We take our responsibility to produce fair, honest and effective communications very seriously and aim continuously to improve our communication with investors and analysts." Enquiries: Acambis plc Lyndsay Wright, VP, Communications and Investor Relations: Tel +44 (0) 1223 275 300 About Acambis Acambis is a leading developer of vaccines to prevent and treat infectious diseases. Recognised internationally as the leading producer of smallpox vaccines, Acambis is developing an investigational smallpox vaccine, ACAM2000, and is manufacturing emergency-use stockpiles of this investigational vaccine for the US Government and other governments around the world. It is also developing an attenuated Attenuated Alive but weakened; an attenuated microorganism can no longer produce disease. Mentioned in: Tuberculin Skin Test attenuated having undergone a process of attenuation. smallpox vaccine, MVA MVA abbr. motor vehicle accident MVA Motor vehicular/vehicle accident, see there 3000, under contracts with the US National Institutes of Health. Acambis is establishing a travel vaccines franchise through its US-based subsidiary Berna Products Corporation, which markets Vivotif(R), the world's only licensed oral typhoid vaccine, in North America. Acambis has other potential travel vaccines in development and is also developing an investigational vaccine against the West Nile virus West Nile virus, microorganism and the infection resulting from it, which typically produces no symptoms or a flulike condition. The virus is a flavivirus and is related to a number of viruses that cause encephalitis. , which has spread to 47 US States in the last six years. Acambis is based in Cambridge, UK and Cambridge, Massachusetts, US. Its primary listing is on the London Stock Exchange London Stock Exchange London marketplace for securities. It was formed in 1773 by a group of stockbrokers who had been doing business informally in local coffeehouses. (ACM) and its shares are listed in the form of American Depositary Receipts on NASDAQ (ACAM). More information is available at www.acambis.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion